John Crudele - New York Post
23 May 2012, 7:56 pm
John Crudele has been a financial columnist for the New York Post for the past two decades.  Before that he was a columnist with New York Magazine, The New York Times, Reuters and various other publications.  His columns have been syndicated around the ...

EMAL named ‘Best Industrial Project in the GCC’ for 2012 - Albawaba
23 May 2012, 5:29 am
Impact Porter Novelli (ipn) is a global public relations leader. In 2009 PRWeek named it the "Agency to Watch" and honored it with its "Innovation of the Year" award. More... You can leave a message using the contact form below.

Top 10 Industrial Sector ETFs - Seekingalpha.com
22 May 2012, 1:02 pm
The 1 YR return was -12.15%. An alternative choice could be SPDR S&P International Industrial Sector ETF (ipn) which follows the S&P Developed Ex-U.S. BMI Industrial Sector Index. It was launched in July 2008. The expense ratio is 0.50%. AUM equal only $11 ...

Active Biotech AB : 600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study - 4-traders (press release)
21 May 2012, 12:38 am
Lund (Sweden) and Paris (France), May 21, 2012, Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: ipn; ADR: IPSEY) today announced that recruitment to the global, pivotal, randomized, double-blind, placebo-controlled phase III study of ...

Mega clinic v family practice - The Mercury
18 May 2012, 9:06 pm
Companies like Independent Practitioner Network have been offering their services to local doctors since 2006. ipn chief executive Malcolm Parmenter said many doctors were happy to have their practices bought and run by companies like his. Dr Parmenter ...

Ipsen, Active Biotech to present data from tasquinimod phase II trial on CRPC at ASCO 2012 - News-Medical.Net
18 May 2012, 3:55 am
Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Paris:ipn) (Euronext: ipn; ADR: IPSEY) will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held in Chicago (USA ...

Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting - msnbc.com
18 May 2012, 1:46 am
LUND, SWEDEN and PARIS — Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: ipn; ADR: IPSEY) will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held ...

Amylin Said to Attract Interest From Pfizer, AstraZeneca - Businessweek
14 May 2012, 6:55 pm
It returned rights to the experimental GLP-1 diabetes drug taspoglutide to developer Ipsen SA (ipn) last year, after patients dropped out of trials because of side effects. Bristol-Myers and London’s AstraZeneca failed to win U.S. clearance ...

Kids show off works of art - KTKA
8 May 2012, 10:29 pm
Kids receiving support from the Family Service and Guidance Center got to show off some of their talents Tuesday night. The center held it's third annual Kids Art Show. Kansas First News morning anchors Hillary Mullin and Tom Hagen served as emcees for the ...